IL17RA and cancer: Given the high levels of inhibitory receptors in CD8+ T cells elicited by T. cruzi infection in absence of IL-17RA, it is likely that the combination of different checkpoint Abs may have a stronger effect in these settings, as reported in cancer models (58).